Nexera Medical
Product Claims: Canada Region Canada European Union European Union


The Next "ERA" in Germ Killing Protection for Health and Safety
 news
Nexera Medical's SpectraShield ™ Plus FFP3 Antimicrobial Respirator Mask passes Virucidal Testing for antimicrobial efficacy at RetroScreen Virology Ltd., a European Union certified testing facility...

January 22, 2009 - Nexera Medical's SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask passes Virucidal Testing for antimicrobial efficacy at RetroScreen Virology Ltd; a European Union certified testing facility. The tests were performed on Influenza A, Avian Influenza H5N1 (Bird Flu), Adenovirus, Human Rhinovirus (common cold), and Coronavirus (related to the SARS category of viruses). The tests concluded that these viruses were inactivated up to 99.4% in periods from 1 to 8 hours and H5N1 (Bird Flu) 43.77% upon immediate contact.

"The passing of antimicrobial testing against viruses establishes an important benchmark in our company's mission to provide healthcare organizations, government agencies, first-responders and the public with this superior product," said Paul Sallarulo, President and Chief Executive Officer of Nexera Medical, Inc. "We believe we are the first to market with approved 'dual-action', broad-spectrum protection antimicrobial respirator mask which may be critical in the event of a major global health crisis. We will continue to enhance our product portfolio to meet the needs of a growing demand for bio-protection products."

Studies, conducted over the past year, were designed to evaluate the mask's antimicrobial properties on a number of viruses. Varying inoculation concentrations of 0 to 6,000,000 units were tested within a time span of 0 hour to 12 hours. This antimicrobial evaluation for our SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask against viruses coincides with previous positive test results for effective kill of bacteria, which was received from the Health Protection Agency in the European Union.

SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask is manufactured using a patented technology; antimicrobial fibers used in the mask incorporate non-toxic silver-copper ionic agents proven safe for extended contact with individuals. Due to SpectraShield™ Plus FFP3's antimicrobial properties, the SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask continuously self-sanitizes itself for extended use.

About Nexera Medical, Inc. Nexera Medical Inc. is engaged in the development, manufacturing and distribution of antimicrobial respirator and surgical masks, as well as other antimicrobial textile based medical products such as medical slings, surgical site aprons and hospital linen products worldwide. The company's mission is to create high-quality, cutting-edge health related medical products designed to safeguard and enhance the quality of human life. All of Nexera's products are designed to provide maximum protection against microorganisms such as bacteria, virus and fungus using Fosshield® patented technology. Nexera partners with governments and leaders in the health care industry in the fight against viral pandemic and other healthcare crises. For more information, visit www.nexeramed.com.

SpectraShield™ Plus FFP3 is a registered trademark of Nexera Medical, Inc.

Newsroom

"Nexera believes that the SpectraShield™ 9900 and SpectraShield™ Plus FFP3 antimicrobial respirator masks are the first antibacterial / antiviral respirator masks of its kind."

Copyright © 2018 Nexera Medical. All rights reserved.